CR-4056 is an analgesic drug candidate with a novel mechanism of action, acting as a ligand for the imidazoline receptor I2.

It showed promising results in animal studies against various types of neuropathic pain, and has reached Phase II human clinical trials as a potential treatment for pain associated with osteoarthritis.

[1][2][3][4][5]

This analgesic-related article is a stub.

You can help Wikipedia by expanding it.